Advertisement
Research Article

Tumor Ablation with Irreversible Electroporation

  • Bassim Al-Sakere,

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Franck André,

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Claire Bernat,

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Elisabeth Connault,

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Paule Opolon,

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Rafael V. Davalos,

    Affiliation: School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, Virginia, United States of America

    X
  • Boris Rubinsky,

    Affiliations: Department of Bioengineering, University of California at Berkeley, Berkeley, California, United States of America, Department of Mechanical Engineering and Graduate Program in Biophysics, University of California at Berkeley, Berkeley, California, United States of America, Center for Bioengineering in the Service of Humanity and Society, School of Computer Science and Engineering, Hebrew University of Jerusalem, Givat Ram, Jerusalem, Israel

    X
  • Lluis M. Mir mail

    To whom correspondence should be addressed. E-mail: luismir@igr.fr

    Affiliations: CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France, University Paris-Sud, UMR 8121, Villejuif, France

    X
  • Published: November 07, 2007
  • DOI: 10.1371/journal.pone.0001135

About the Authors

Bassim Al-Sakere, Franck André, Claire Bernat, Elisabeth Connault, Paule Opolon, Lluis M. Mir
CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France
Bassim Al-Sakere, Franck André, Claire Bernat, Elisabeth Connault, Paule Opolon, Lluis M. Mir
University Paris-Sud, UMR 8121, Villejuif, France
Rafael V. Davalos
School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, Virginia, United States of America
Boris Rubinsky
Department of Bioengineering, University of California at Berkeley, Berkeley, California, United States of America
Boris Rubinsky
Department of Mechanical Engineering and Graduate Program in Biophysics, University of California at Berkeley, Berkeley, California, United States of America
Boris Rubinsky
Center for Bioengineering in the Service of Humanity and Society, School of Computer Science and Engineering, Hebrew University of Jerusalem, Givat Ram, Jerusalem, Israel

Corresponding Author

Email: luismir@igr.fr

Competing Interests

R. Davalos and B. Rubinsky have potential interests in the revenues of pending patents held by Univ. of California at Berkeley (e.g. No 10/571,162, Tissue Ablation with Irreversible Electroporation). B. Rubinsky also has a financial interest in Excellin Life Sciences and in Oncobionic, companies in the field of electroporation. L. M. Mir was a consultant for Oncobionics.

Author Contributions

Conceived and designed the experiments: BR LM RD. Performed the experiments: PO BA FA CB EC. Analyzed the data: PO BR LM BA FA RD. Contributed reagents/materials/analysis tools: PO. Wrote the paper: BR LM RD.